ReviewFrontiers in immunology2017
Sphingolipids Are Dual Specific Drug Targets for the Management of Pulmonary Infections: Perspective.
Lalita Sharma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papertrialcites it